Low-dose aspirin could help decrease the risk of developing cancer by 25 percent, says study.
Zalutumumab Prolongs Survival of Patients With Incurable Head and Neck Cancer
Head & Neck Cancer of squamous type that no longer responding to chemotherapy may respond to zalutumumab
Head & Neck Cancer of squamous type that no longer responding to chemotherapy may respond to zalutumumab
They found that people were 22 percent more likely to avoid developing head and neck cancers if they took aspirin on a weekly and monthly basis.
The medicine pill, dubbed "wonderdrug," was most effective in throat cancer prevention.
Head and Neck Cancer Molecular Tumor Subtypes Highlighted in UNC-Led Study
Except an association with the human papillomavirus, no validated molecular profile of head and neck squamous cell carcinoma (HNSCC) has been established.
Except an association with the human papillomavirus, no validated molecular profile of head and neck squamous cell carcinoma (HNSCC) has been established.
The study has been published in the British Journal of Cancer.
Advertisement
Canadian Study Assesses Who is Taking Aspirin to Prevent Heart Attack or Stroke
A large population of healthy people are taking Aspirin to prevent cardiovascular disease, a new study out of the Faculty of Medicine & Dentistry shows.
A large population of healthy people are taking Aspirin to prevent cardiovascular disease, a new study out of the Faculty of Medicine & Dentistry shows.
Skin Cancer Risk Lowered in Women With Prolonged Intake of Aspirin
Regular intake of aspirin for longer duration could drastically reduce the risk of skin cancer in women, claims a new research conducted by the Women's Health Initiative.
Regular intake of aspirin for longer duration could drastically reduce the risk of skin cancer in women, claims a new research conducted by the Women's Health Initiative.
